BL

Borys Lytovskyi

Director Director DIN 02015623
DIN 02015623 First appointment Nov 2001 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2001
Shareholding value •••• Premium profile

About Borys Lytovskyi

Data last updated:

Borys Lytovskyi was a Director at Mili Healthcare Private Limited (2001–2012) and Director at Swift Healthcare Private Limited (2003–2011). The companies operate in Pharma and Chemicals.

DIN 02015623
Primary Designation Director
Industry Pharma
First Appointment 22 Nov 2001

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mili Healthcare Private Limited U24231DL2001PTC113247
Director22 Nov 20012001₹62,770 (FY 2024)Active
Swift Healthcare Private Limited U24231DL2002PTC117864
Director16 Jan 20032002Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mili Healthcare Private Limited
Swift Healthcare Private Limited
Premium access

Shareholding and investment profile for Borys Lytovskyi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Borys Lytovskyi

Borys Lytovskyi was first appointed on 22 Nov 2001 as Director at Mili Healthcare Private Limited. The most recent appointment on record is 16 Jan 2003 at Swift Healthcare Private Limited.

Borys Lytovskyi held 2 earlier board appointments: Mili Healthcare Private Limited (Director, 22 Nov 2001 to 02 Feb 2012); Swift Healthcare Private Limited (Director, 16 Jan 2003 to 02 Nov 2011).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available